[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100326406":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":23,"centralContacts":28,"locations":37,"responsibleParty":52,"collaborators":54,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":61,"acronym":10,"eligibilityCriteria":62,"healthyVolunteers":59,"sex":63,"minAge":64,"maxAge":10,"enrollmentInfo":65,"targetDuration":68,"studyType":69,"phases":10,"briefSummary":70,"conditions":71,"keywords":10,"overallStatus":39,"whyStopped":10,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Universitaire Ziekenhuizen KU Leuven","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Critically ill patients",null,"Patients admitted on ICU.",[13],"Other: Sample collection",{"label":15,"type":10,"description":16,"interventionNames":17},"Hematology patients","Patients admitted on the hematology ward.",[13],[19],{"type":6,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"Sample collection","Plasma, urine, BAL and ascitic fluid sample collection.",[9,15],[24],{"name":25,"affiliation":26,"role":27},"Isabel Spriet, PharmD, PhD","UZ Leuven","PRINCIPAL_INVESTIGATOR",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"Ruth Van Daele, PharmD","CONTACT","+3216343264","ruth.vandaele@uzleuven.be",{"name":25,"role":31,"phone":35,"phoneExt":10,"email":36},"+3216341261","isabel.spriet@uzleuven.be",[38],{"facility":26,"status":39,"city":40,"state":10,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","Leuven","3000","Belgium","BE",{"type":45,"coordinates":46},"Point",[47,48],4.70093,50.87959,{"lat":48,"lon":47},[51],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},{"type":53,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[55],{"name":56,"class":6},"KU Leuven","100326406","pharmacokinetics-of-liposomal-amphotericin-b-in-critically-ill-vs-non-critically-ill-hematological-patients-exploration-of-covariates-100326406",false,"NCT03529617","Pharmacokinetics of Liposomal Amphotericin B in Critically Ill vs. Non-critically Ill Hematological Patients: Exploration of Covariates","Inclusion Criteria:\n\n* Treatment with L-AmB\n* Admitted to an ICU or Hematology ward\n\nExclusion Criteria:\n\n* DNR 2 or 3\n* Pregnant or lactating women\n* Previous documentation of intolerance\u002Fsensitivity to L-AmB","ALL","18 Years",{"count":66,"type":67},60,"ESTIMATED","1 Month","OBSERVATIONAL","This prospective study will compare the pharmacokinetic exposure to liposomal amphotericin B between critically ill patients and non-critically ill (hematology) patients in an early and late exposure day.",[72,73,74],"Pharmacokinetics","Liposomal Amphotericin B","Critically Ill Patients","2024-07-02",{"date":77,"type":78},"2024-07-03","ACTUAL",{"date":80,"type":78},"2016-10-19",{"date":82,"type":67},"2025-12-31",{"name":5,"class":6},1]